Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04954313Phase 4Completed
Phase 4, randomised, open-label trial (2 arms), sponsored by University of North Carolina at Chapel Hill. Primary endpoints: Change in Oral Health Measures at 360 days, Association Between Changes in Oral Health (Probing Depth) and Changes in Systemic Health (HbA1c) at 360 days and 1 more. Started Sep 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04954313.